Browse result page of SalivaDB
This is the result page of the browse module of SalivaDB. This page gives the information about the query submitted by the user as per the browse category. Further details of the entries can be seen by clicking on the SAL_ID. Further the user can sort the entries on the basis of various fields by clicking on the respective headers. The user can also download the results in various formats.
Tabular representation:
SAL_ID | Biomarker Name | Biomarker Type | Analysis Method | Collection Site | Disease/Condition Category | Disease/Condition | Disease/Condition Subtype | Fold Change | Regulation | Exosomal Origin | Organism | PMID | YOP | External Links | Biomarker Category | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SAL_10114 | Angiogenin | NA | ELISA + Nano-HPLC-MS/Msanalyses | Saliva | Immune System Disorder | Sjogren's Syndrome | Primary Sjogren's syndrome | NA | NA | NA | Homo sapiens | 29558726 | 2018 | P03950 | ProteinSAL_10115 | Catenin Alpha 3 | NA | ELISA + Nano-HPLC-MS/Msanalyses | Saliva | Immune System Disorder | Sjogren's Syndrome | Primary Sjogren's syndrome | 1.97 | upregulated | NA | Homo sapiens | 29558726 | 2018 | Q9UI47 | Protein | SAL_10116 | Chromodomain-helicase-DNA-binding protein 9 | NA | ELISA + Nano-HPLC-MS/Msanalyses | Saliva | Immune System Disorder | Sjogren's Syndrome | Primary Sjogren's syndrome | NA | NA | NA | Homo sapiens | 29558726 | 2018 | Q3L8U1 | Protein | SAL_10117 | Corticosteroid-binding globulin | NA | ELISA + Nano-HPLC-MS/Msanalyses | Saliva | Immune System Disorder | Sjogren's Syndrome | Primary Sjogren's syndrome | NA | NA | NA | Homo sapiens | 29558726 | 2018 | P08185 | Protein | SAL_10118 | Dipeptidyl peptidase 1 | NA | ELISA + Nano-HPLC-MS/Msanalyses | Saliva | Immune System Disorder | Sjogren's Syndrome | Primary Sjogren's syndrome | NA | NA | NA | Homo sapiens | 29558726 | 2018 | P53634 | Protein | SAL_10119 | DNA topoisomerase 1 | NA | ELISA + Nano-HPLC-MS/Msanalyses | Saliva | Immune System Disorder | Sjogren's Syndrome | Primary Sjogren's syndrome | NA | NA | NA | Homo sapiens | 29558726 | 2018 | P11387 | Protein | SAL_10120 | Glutathione peroxidase 6 | NA | ELISA + Nano-HPLC-MS/Msanalyses | Saliva | Immune System Disorder | Sjogren's Syndrome | Primary Sjogren's syndrome | NA | NA | NA | Homo sapiens | 29558726 | 2018 | P59796 | Protein | SAL_10121 | KCNN4 | NA | ELISA + Nano-HPLC-MS/Msanalyses | Saliva | Immune System Disorder | Sjogren's Syndrome | Primary Sjogren's syndrome | 2.45 | upregulated | NA | Homo sapiens | 29558726 | 2018 | O15554 | Protein | SAL_10122 | Ninein | NA | ELISA + Nano-HPLC-MS/Msanalyses | Saliva | Immune System Disorder | Sjogren's Syndrome | Primary Sjogren's syndrome | NA | NA | NA | Homo sapiens | 29558726 | 2018 | Q8N4C6 | Protein | SAL_10123 | Protein Bbs1 | NA | ELISA + Nano-HPLC-MS/Msanalyses | Saliva | Immune System Disorder | Sjogren's Syndrome | Primary Sjogren's syndrome | NA | NA | NA | Homo sapiens | 29558726 | 2018 | Q8NFJ9 | Protein | SAL_10124 | Kinetochore scaffold 1 | NA | ELISA + Nano-HPLC-MS/Msanalyses | Saliva | Immune System Disorder | Sjogren's Syndrome | Primary Sjogren's syndrome | NA | NA | NA | Homo sapiens | 29558726 | 2018 | Q8NG31 | Protein | SAL_10125 | Dynein axonemal heavy chain 14 | NA | ELISA + Nano-HPLC-MS/Msanalyses | Saliva | Immune System Disorder | Sjogren's Syndrome | Primary Sjogren's syndrome | NA | NA | NA | Homo sapiens | 29558726 | 2018 | Q0VDD8 | Protein | SAL_10126 | PTPN6 | NA | ELISA + Nano-HPLC-MS/Msanalyses | Saliva | Immune System Disorder | Sjogren's Syndrome | Primary Sjogren's syndrome | 1.52 | upregulated | NA | Homo sapiens | 29558726 | 2018 | P29350 | Protein | SAL_10127 | RAC2 | NA | ELISA + Nano-HPLC-MS/Msanalyses | Saliva | Immune System Disorder | Sjogren's Syndrome | Primary Sjogren's syndrome | 1.77 | upregulated | NA | Homo sapiens | 29558726 | 2018 | P15153 | Protein | SAL_10128 | Renin-2 | NA | ELISA + Nano-HPLC-MS/Msanalyses | Saliva | Immune System Disorder | Sjogren's Syndrome | Primary Sjogren's syndrome | NA | NA | NA | Homo sapiens | 29558726 | 2018 | P00797 | Protein | SAL_10129 | Secretoglobin family 2 B member 24 | NA | ELISA + Nano-HPLC-MS/Msanalyses | Saliva | Immune System Disorder | Sjogren's Syndrome | Primary Sjogren's syndrome | NA | NA | NA | Homo sapiens | 29558726 | 2018 | P11684 | Protein | SAL_10130 | Submandibular gland protein C | NA | ELISA + Nano-HPLC-MS/Msanalyses | Saliva | Immune System Disorder | Sjogren's Syndrome | Primary Sjogren's syndrome | NA | NA | NA | Homo sapiens | 29558726 | 2018 | Q6V7X9 | Protein | SAL_10131 | TLR4 interactor with leucine-rich repeats | NA | ELISA + Nano-HPLC-MS/Msanalyses | Saliva | Immune System Disorder | Sjogren's Syndrome | Primary Sjogren's syndrome | NA | NA | NA | Homo sapiens | 29558726 | 2018 | Q7L0X0 | Protein | SAL_10132 | UDP-glucuronosyltransferase | NA | ELISA + Nano-HPLC-MS/Msanalyses | Saliva | Immune System Disorder | Sjogren's Syndrome | Primary Sjogren's syndrome | NA | NA | NA | Homo sapiens | 29558726 | 2018 | P19224 | Protein | SAL_10133 | WAP four-disulfide core domain protein 12 | NA | ELISA + Nano-HPLC-MS/Msanalyses | Saliva | Immune System Disorder | Sjogren's Syndrome | Primary Sjogren's syndrome | NA | NA | NA | Homo sapiens | 29558726 | 2018 | Q8WWY7 | Protein | SAL_11857 | Acidic proline-rich proteins | NA | HPLC-ESI-MS | Whole Saliva | Immune System Disorder | antibody deficiencies | NA | NA | NA | NA | Homo sapiens | 31916122 | 2020 | Q96NZ9 | Protein | SAL_11858 | Antileukoproteinase | NA | HPLC-ESI-MS | Whole Saliva | Immune System Disorder | antibody deficiencies | NA | NA | NA | NA | Homo sapiens | 31916122 | 2020 | P03973 | Protein | SAL_11859 | Cystatin B | NA | HPLC-ESI-MS | Whole Saliva | Immune System Disorder | antibody deficiencies | NA | NA | Upregulated | NA | Homo sapiens | 31916122 | 2020 | P04080 | Protein | SAL_11860 | Cystatin S1 | NA | HPLC-ESI-MS | Whole Saliva | Immune System Disorder | antibody deficiencies | NA | NA | Downregulated | NA | Homo sapiens | 31916122 | 2020 | P01036 | Protein | SAL_11861 | Cystatin S2 | NA | HPLC-ESI-MS | Whole Saliva | Immune System Disorder | antibody deficiencies | NA | NA | Downregulated | NA | Homo sapiens | 31916122 | 2020 | P01036 | Protein | SAL_11862 | Cystatin SN | NA | HPLC-ESI-MS | Whole Saliva | Immune System Disorder | antibody deficiencies | NA | NA | Upregulated | NA | Homo sapiens | 31916122 | 2020 | P01037 | Protein | SAL_11863 | Histatin-1 | NA | HPLC-ESI-MS | Whole Saliva | Immune System Disorder | antibody deficiencies | NA | NA | NA | NA | Homo sapiens | 31916122 | 2020 | P15515 | Protein | SAL_11864 | Histatin-3 1-24 | NA | HPLC-ESI-MS | Whole Saliva | Immune System Disorder | antibody deficiencies | NA | NA | NA | NA | Homo sapiens | 31916122 | 2020 | P15516 | Protein | SAL_11865 | Histatin-3 1-25 | NA | HPLC-ESI-MS | Whole Saliva | Immune System Disorder | antibody deficiencies | NA | NA | NA | NA | Homo sapiens | 31916122 | 2020 | P15516 | Protein | SAL_11866 | P-B peptide | NA | HPLC-ESI-MS | Whole Saliva | Immune System Disorder | antibody deficiencies | NA | NA | NA | NA | Homo sapiens | 31916122 | 2020 | NA | Protein | SAL_11867 | Prolactin-inducible protein | NA | HPLC-ESI-MS | Whole Saliva | Immune System Disorder | antibody deficiencies | NA | NA | NA | NA | Homo sapiens | 31916122 | 2020 | P12273 | Protein | SAL_11868 | S100A12 | NA | HPLC-ESI-MS | Whole Saliva | Immune System Disorder | antibody deficiencies | NA | NA | NA | NA | Homo sapiens | 31916122 | 2020 | P80511 | Protein | SAL_11869 | S100A7 | NA | HPLC-ESI-MS | Whole Saliva | Immune System Disorder | antibody deficiencies | NA | NA | NA | NA | Homo sapiens | 31916122 | 2020 | P31151 | Protein | SAL_11870 | S100A8 | NA | HPLC-ESI-MS | Whole Saliva | Immune System Disorder | antibody deficiencies | NA | NA | NA | NA | Homo sapiens | 31916122 | 2020 | P05109 | Protein | SAL_11871 | S100A9 | NA | HPLC-ESI-MS | Whole Saliva | Immune System Disorder | antibody deficiencies | NA | NA | NA | NA | Homo sapiens | 31916122 | 2020 | P06702 | Protein | SAL_11872 | Statherin | NA | HPLC-ESI-MS | Whole Saliva | Immune System Disorder | antibody deficiencies | NA | NA | NA | NA | Homo sapiens | 31916122 | 2020 | P02808 | Protein | SAL_11873 | Thymosin beta-10 | NA | HPLC-ESI-MS | Whole Saliva | Immune System Disorder | antibody deficiencies | NA | NA | NA | NA | Homo sapiens | 31916122 | 2020 | P63313 | Protein | SAL_11874 | Thymosin beta-4 | NA | HPLC-ESI-MS | Whole Saliva | Immune System Disorder | antibody deficiencies | NA | NA | NA | NA | Homo sapiens | 31916122 | 2020 | P62328 | Protein | SAL_13087 | Protein S100-A6 (Calcyclin) (Growth factor-inducible protein 2A9) (MLN 4) (Prolactin receptor-associated protein) (PRA) (S100 calcium-binding protein A6) | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | NA | NA | Homo sapiens | 17436266 | 2007 | P06703 | Protein | SAL_13088 | Glutathione S-transferase P (EC 2.5.1.18) (GST class-pi) (GSTP1-1) | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | Upregulated | NA | Homo sapiens | 17436266 | 2007 | P09211 | Protein | SAL_13089 | Beta-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 3) (Muscle-specific enolase) (MSE) (Skeletal muscle enolase) | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | NA | NA | Homo sapiens | 17436266 | 2007 | P13929 | Protein | SAL_13092 | Protein disulfide-isomerase A3 (EC 5.3.4.1) (58 kDa glucose-regulated protein) (58 kDa microsomal protein) (p58) (Disulfide isomerase ER-60) (Endoplasmic reticulum resident protein 57) (ER protein 57) | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | NA | NA | Homo sapiens | 17436266 | 2007 | P30101 | Protein | SAL_13093 | Leukocyte elastase inhibitor (LEI) (Monocyte/neutrophil elastase inhibitor) (EI) (M/NEI) (Peptidase inhibitor 2) (PI-2) (Serpin B1) | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | Upregulated | NA | Homo sapiens | 17436266 | 2007 | P30740 | Protein | SAL_13094 | Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed] | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | Upregulated | NA | Homo sapiens | 17436266 | 2007 | P60709 | Protein | SAL_13096 | Actin, cytoplasmic 2 (Gamma-actin) [Cleaved into: Actin, cytoplasmic 2, N-terminally processed] | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | Upregulated | NA | Homo sapiens | 17436266 | 2007 | P63261 | Protein | SAL_13097 | Fatty acid-binding protein, epidermal (Epidermal-type fatty acid-binding protein) (E-FABP) (Fatty acid-binding protein 5) (Psoriasis-associated fatty acid-binding protein homolog) (PA-FABP) | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | Upregulated | NA | Homo sapiens | 17436266 | 2007 | Q01469 | Protein | SAL_13100 | Dolichol-phosphate mannosyltransferase subunit 3 (Dolichol-phosphate mannose synthase subunit 3) (DPM synthase subunit 3) (Dolichyl-phosphate beta-D-mannosyltransferase subunit 3) (Mannose-P-dolichol | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | NA | NA | Homo sapiens | 17436266 | 2007 | Q9P2X0 | Protein | SAL_13887 | Aflatoxin B1 aldehyde reductase member 2 (EC 1.1.1.n11) (AFB1 aldehyde reductase 1) (AFB1-AR 1) (Aldoketoreductase 7) (Succinic semialdehyde reductase) (SSA reductase) | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | NA | NA | Homo sapiens | 17968930 | 2007 | O43488 | Protein | SAL_13888 | Carbonic anhydrase 1 (EC 4.2.1.1) (Carbonate dehydratase I) (Carbonic anhydrase B) (CAB) (Carbonic anhydrase I) (CA-I) | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | Upregulated | NA | Homo sapiens | 17968930 | 2007 | P00915 | Protein | SAL_13889 | Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | Upregulated | NA | Homo sapiens | 17968930 | 2007 | P00918 | Protein | SAL_13890 | Ig kappa chain C region | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | Upregulated | NA | Homo sapiens | 17968930 | 2007 | P01834 | Protein | SAL_13891 | Ig epsilon chain C region | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | Upregulated | NA | Homo sapiens | 17968930 | 2007 | P01854 | Protein | SAL_13892 | Ig gamma-1 chain C region | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | Upregulated | NA | Homo sapiens | 17968930 | 2007 | P01857 | Protein | SAL_13893 | Fructose-bisphosphate aldolase A (EC 4.1.2.13) (Lung cancer antigen NY-LU-1) (Muscle-type aldolase) | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | Upregulated | NA | Homo sapiens | 17968930 | 2007 | P04075 | Protein | SAL_13894 | Alpha-amylase 1 (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase 1) (Salivary alpha-amylase) | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | Upregulated | NA | Homo sapiens | 17968930 | 2007 | P04745 | Protein | SAL_13895 | ATP synthase subunit beta, mitochondrial (EC 3.6.3.14) | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | NA | NA | Homo sapiens | 17968930 | 2007 | P06576 | Protein | SAL_13896 | Protein S100-A9 (Calgranulin-B) (Calprotectin L1H subunit) (Leukocyte L1 complex heavy chain) (Migration inhibitory factor-related protein 14) (MRP-14) (p14) (S100 calcium-binding protein A9) | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | Upregulated | NA | Homo sapiens | 17968930 | 2007 | P06702 | Protein | SAL_13897 | Protein S100-A9 (Calgranulin-B) (Calprotectin L1H subunit) (Leukocyte L1 complex heavy chain) (Migration inhibitory factor-related protein 14) (MRP-14) (p14) (S100 calcium-binding protein A9) | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | NA | NA | Homo sapiens | 17968930 | 2007 | P06702 | Protein | SAL_13898 | Alpha-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (C-myc promoter-binding protein) (Enolase 1) (MBP-1) (MPB-1) (Non-neural enolase) (NNE) (Phosphopyruvate hydratase) (Plasminogen-binding | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | Upregulated | NA | Homo sapiens | 17968930 | 2007 | P06733 | Protein | SAL_13899 | Alpha-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (C-myc promoter-binding protein) (Enolase 1) (MBP-1) (MPB-1) (Non-neural enolase) (NNE) (Phosphopyruvate hydratase) (Plasminogen-binding | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | NA | NA | Homo sapiens | 17968930 | 2007 | P06733 | Protein | SAL_13900 | Tropomyosin beta chain (Beta-tropomyosin) (Tropomyosin-2) | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | NA | NA | Homo sapiens | 17968930 | 2007 | P07951 | Protein | SAL_13901 | Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate decarboxylase) (EC 4.1.1.15) (Glutamate--ammonia ligase) | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | NA | NA | Homo sapiens | 17968930 | 2007 | P15104 | Protein | SAL_13902 | Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform (Medium tumor antigen-associated 61 kDa protein) (PP2A subunit A isoform PR65-alpha) (PP2A subunit A isoform R1-alpha) | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | NA | NA | Homo sapiens | 17968930 | 2007 | P30153 | Protein | SAL_13903 | Protein S100-A7 (Psoriasin) (S100 calcium-binding protein A7) | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | Upregulated | NA | Homo sapiens | 17968930 | 2007 | P31151 | Protein | SAL_13904 | Caspase-14 (CASP-14) (EC 3.4.22.-) [Cleaved into: Caspase-14 subunit p17, mature form; Caspase-14 subunit p10, mature form; Caspase-14 subunit p20, intermediate form; Caspase-14 subunit p8, intermedia | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | Upregulated | NA | Homo sapiens | 17968930 | 2007 | P31944 | Protein | SAL_13905 | Histone H2B type 1-D (HIRA-interacting protein 2) (Histone H2B.1 B) (Histone H2B.b) (H2B/b) | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | NA | NA | Homo sapiens | 17968930 | 2007 | P58876 | Protein | SAL_13906 | Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed] | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | Upregulated | NA | Homo sapiens | 17968930 | 2007 | P60709 | Protein | SAL_13907 | Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3] | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | Upregulated | NA | Homo sapiens | 17968930 | 2007 | P61769 | Protein | SAL_13908 | Serine/threonine-protein phosphatase PP1-beta catalytic subunit (PP-1B) (PPP1CD) (EC 3.1.3.16) (EC 3.1.3.53) | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | NA | NA | Homo sapiens | 17968930 | 2007 | P62140 | Protein | SAL_13909 | Hemoglobin subunit beta (Beta-globin) (Hemoglobin beta chain) [Cleaved into: LVV-hemorphin-7; Spinorphin] | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | Upregulated | NA | Homo sapiens | 17968930 | 2007 | P68871 | Protein | SAL_13910 | Hemoglobin subunit alpha (Alpha-globin) (Hemoglobin alpha chain) | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | Upregulated | NA | Homo sapiens | 17968930 | 2007 | P69905 | Protein | SAL_13911 | Fatty acid-binding protein, epidermal (Epidermal-type fatty acid-binding protein) (E-FABP) (Fatty acid-binding protein 5) (Psoriasis-associated fatty acid-binding protein homolog) (PA-FABP) | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | Upregulated | NA | Homo sapiens | 17968930 | 2007 | Q01469 | Protein | SAL_13912 | Ubiquitin-conjugating enzyme E2 variant 2 (DDVit 1) (Enterocyte differentiation-associated factor 1) (EDAF-1) (Enterocyte differentiation-promoting factor 1) (EDPF-1) (MMS2 homolog) (Vitamin D3-induci | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | NA | NA | Homo sapiens | 17968930 | 2007 | Q15819 | Protein | SAL_13913 | Serum albumin | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | Upregulated | NA | Homo sapiens | 17968930 | 2007 | Q56G89 | Protein | SAL_13914 | Putative uncharacterized protein DKFZp686I15196 | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | Upregulated | NA | Homo sapiens | 17968930 | 2007 | Q6N096 | Protein | SAL_14200 | Ig gamma-1 chain C region | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | Upregulated | NA | Homo sapiens | 18939961 | 2009 | P01857 | Protein | SAL_14201 | Serum albumin | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | Upregulated | NA | Homo sapiens | 18939961 | 2009 | P02768 | Protein | SAL_14202 | Keratin, type II cytoskeletal 1 (67 kDa cytokeratin) (Cytokeratin-1) (CK-1) (Hair alpha protein) (Keratin-1) (K1) (Type-II keratin Kb1) | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | Upregulated | NA | Homo sapiens | 18939961 | 2009 | P04264 | Protein | SAL_14203 | Protein S100-A8 (Calgranulin-A) (Calprotectin L1L subunit) (Cystic fibrosis antigen) (CFAG) (Leukocyte L1 complex light chain) (Migration inhibitory factor-related protein 8) (MRP-8) (p8) (S100 calciu | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | Upregulated | NA | Homo sapiens | 18939961 | 2009 | P05109 | Protein | SAL_14204 | Protein S100-A9 (Calgranulin-B) (Calprotectin L1H subunit) (Leukocyte L1 complex heavy chain) (Migration inhibitory factor-related protein 14) (MRP-14) (p14) (S100 calcium-binding protein A9) | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | Upregulated | NA | Homo sapiens | 18939961 | 2009 | P06702 | Protein | SAL_14205 | Tropomyosin beta chain (Beta-tropomyosin) (Tropomyosin-2) | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | NA | NA | Homo sapiens | 18939961 | 2009 | P07951 | Protein | SAL_14206 | Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) (Helix-destabilizing protein) (Single-strand RNA-binding protein) (hnRNP core protein A1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein A | NA | NA | Whole Saliva | Immune System Disorder | Sjogren's Syndrome | NA | NA | NA | NA | Homo sapiens | 18939961 | 2009 | P09651 | Protein | |